Default: American Journal of Hematology

ISSN: 0361-8609

Journal Home

Journal Guideline

American Journal of Hematology Q1 Unclaimed

Wiley-Liss Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

American Journal of Hematology is a journal indexed in SJR in Hematology with an H index of 121. It has a price of 3500 €. It has an SJR impact factor of 2,901 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,901.

American Journal of Hematology focuses its scope in these topics and keywords: cell, leukemia, lymphoma, disease, iron, survival, syndrome, hematopoietic, myelodysplastic, anemia, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Hematology (Q1)

3500 €

Inmediate OA


Embargoed OA

0 €

Non OA


American Journal of Hematology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

cell, leukemia, lymphoma, disease, iron, survival, syndrome, hematopoietic, myelodysplastic, anemia, stem, chronic, immunoglobulin, myeloma, review, patients, intravenous, multiple, lymphomas, prophylaxis,

Best articles by citations

Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia

View more

Long-standing Bell's palsy and ipsilateral conjunctival maltoma

View more

Acute pancreatitis during sickle cell vaso-occlusive painful crisis

View more

Bulky plasmacytoma of the skull with intracranial involvement

View more

A non-immunological phospholipid-dependent coagulation inhibitor associated with IgG?-type multiple myeloma

View more

Philadelphia chromosome-positive acute lymphoblastic leukemia after therapy for langerhans cell histiocytosis

View more

Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified fromEscherichia coli O157

View more

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study

View more

Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia

View more

Venous thromboembolism prevention in the acutely ill medical patient: A review of the literature and focus on special patient populations

View more

Clumping of plasma cells: A pitfall in the diagnosis of plasma cell leukemia

View more

Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome

View more

Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin

View more

Immune thrombocytopenia attributed to brucellosis and other mechanisms ofBrucella-induced thrombocytopenia

View more

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial

View more

Residual leukemic blasts or regenerating normal precursors? The hematologist's dilemma

View more

Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: Complete remission associated with highly active antiretroviral therapy

View more

Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases

View more

Case of Schwachman's syndrome with intermittent neutropenia and lymphocyte subset disturbances

View more

Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation

View more

Pancytopenia due to extensive hemophagocytosis following anti-tubercular treatment

View more

Ureteric obstruction by retroperitoneal lymphoplasmacytic lymphoma

View more

Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders

View more

First observation of homozygous hemoglobin hamadan (B 56 (D7) GLY-ARG) and beta thalassemia (-29 G>A)- hemoglobin Hamadan combination in a Turkish family

View more